Author: Murray M.D.
Publisher: Adis International
ISSN: 1173-2563
Source: Clinical Drug Investigation, Vol.16, Iss.1, 1998-07, pp. : 45-52
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Healthcare Costs of Patients with Heart Failure Treated with Torasemide or Furosemide
By Stroupe K.T.
PharmacoEconomics, Vol. 17, Iss. 5, 2000-05 ,pp. :
Torasemide outshines furosemide in QOL stakes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 444, 2004-01 ,pp. :
Torasemide: A Pharmacoeconomic Review of its Use in Chronic Heart Failure
PharmacoEconomics, Vol. 19, Iss. 6, 2001-06 ,pp. :
Furosemide and hypertonic saline for advanced heart failure
Inpharma, Vol. 1, Iss. 1388, 2003-01 ,pp. :